[Italian guidelines for the diagnosis and treatment of Paget's disease of bone].

Paget's disease of bone is a chronic focal abnormality of bone turnover that remains totally asymptomatic over a very long period of time but that eventually ensue in bone pain and skeletal deformities. Although, in the last decade new insights have been obtained on its etiology, this remains largely obscure. Effective medical treatment (based on the use of bisphosphonates) has become available and the diagnostic procedures are now well defined. However, there remains considerable controversy regarding the hierarchy of diagnostic procedures and the medical treatment threshold. In the last few years different institution have published national guidelines, reflecting local national health systems and the available medical treatment. In this review, a working group derived from members of the SIOMMMS has examined the information available regarding the diagnosis and treatment of Paget's disease in order to develop guidelines to assist in the management of this condition. The first draft was then extensively reviewed by experts derived from the most representative scientific societies of rheumatology, internal medicine, and orthopaedic surgery. The document provides the most updated recommendations based primarily on the "evidence-based- medicine" but also on the Italian regulation for the diagnostic procedures and on the available medical treatments.

[1]  Pasquale Strazzullo,et al.  Evidence for Increased Clinical Severity of Familial and Sporadic Paget's Disease of Bone in Campania, Southern Italy , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Jacques P. Brown,et al.  Long‐Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  J. Walsh,et al.  A Novel Mutation (K378X) in the Sequestosome 1 Gene Associated With Increased NF‐κB Signaling and Paget's Disease of Bone With a Severe Phenotype , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  G. H. Nancollas,et al.  Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. , 2006, Bone.

[5]  R. Nuti,et al.  Prevalence of Paget's Disease of Bone in Italy , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Jacques P. Brown,et al.  Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. , 2005, The New England journal of medicine.

[7]  R. Nuti,et al.  Characteristics and Familial Aggregation of Paget's Disease of Bone in Italy , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  M. Brandi,et al.  Two Novel Mutations at Exon 8 of the Sequestosome 1 (SQSTM1) Gene in an Italian Series of Patients Affected by Paget's Disease of Bone (PDB) , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  C. Cooper,et al.  Incidence and Natural History of Paget's Disease of Bone in England and Wales , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  W. O'Fallon,et al.  Fracture Risk Among Patients with Paget's Disease: A Population‐Based Cohort Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  C. Hayes,et al.  Improvement of pagetic bone lesions with risedronate treatment: a radiologic study. , 2000, Bone.

[12]  M. Porter,et al.  Charnley low-friction arthroplasty for Paget's disease of the hip. , 2000, The Journal of arthroplasty.

[13]  C. Mautalen,et al.  Short‐Term Therapy with Oral Olpadronate in Active Paget's Disease of Bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  S. Vasikaran,et al.  Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  P. Selby Pamidronate in the treatment of Paget's disease. , 1999, Bone.

[16]  A. Grauer,et al.  Ibandronate treatment in Paget's disease of bone. , 1999, Bone.

[17]  Jacques P. Brown,et al.  A randomized, double-blind comparison of risedronate and etidronate in the treatment of paget’s disease of bone , 1999 .

[18]  J. Reginster,et al.  Risedronate, a Highly Effective, Short-Term Oral Treatment for Paget's Disease: A Dose-Response Study , 1999, Calcified Tissue International.

[19]  E. Dennison,et al.  The Epidemiology of Paget's Disease in Britain: Is the Prevalence Decreasing? , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  P. Filipponi,et al.  Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate. , 1998, Bone.

[21]  S. Ralston,et al.  Genetics of Paget's disease of bone. , 1998, Clinical science.

[22]  Jacques P. Brown,et al.  Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  P. Delmas,et al.  Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. , 1998, Arthritis and rheumatism.

[24]  W. Fraser,et al.  A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone. , 1997, Postgraduate medical journal.

[25]  E. Siris,et al.  Antiresorptive Effect of a Single Infusion of Microgram Quantities of Zoledronate in Paget's Disease of Bone , 1997, Calcified Tissue International.

[26]  J. Kanis,et al.  Alendronate in the treatment of Paget's disease of bone. , 1997, Bone.

[27]  D. Gold,et al.  Paget's disease of bone and quality of life , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  W. Murphy,et al.  Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. , 1996, The American journal of medicine.

[29]  W. Murphy,et al.  Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. , 1996, The Journal of clinical endocrinology and metabolism.

[30]  G. Fabry,et al.  The Ilizarov External Fixator for Treatment of Deformities in Paget's Disease , 1996, Clinical orthopaedics and related research.

[31]  I. Reid,et al.  Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. , 1995, Archives of internal medicine.

[32]  N. P. O’Donnell,et al.  PAGET'S DISEASE: OCULAR COMPLICATIONS OF DISODIUM PAMIDRONATE TREATMENT , 1995, The British journal of clinical practice.

[33]  M. Dougados,et al.  Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. , 1995, Arthritis and rheumatism.

[34]  R. Deulofeu,et al.  Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  F. Fraunfelder,et al.  Pamidronate disodium and possible ocular adverse drug reactions. , 1994, American journal of ophthalmology.

[36]  S. Adami,et al.  Effects of two oral doses of alendronate in the treatment of Paget's disease of bone. , 1994, Bone.

[37]  J. Highton,et al.  Uveitis associated with pamidronate. , 1994, Australian and New Zealand journal of medicine.

[38]  P. Filipponi,et al.  Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed. , 1994, Bone.

[39]  S. Adami,et al.  Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. , 1994, Bone and mineral.

[40]  R. Watts,et al.  Treatment of Paget's disease of bone with single dose intravenous pamidronate. , 1994, Annals of the Rheumatic Diseases.

[41]  S. Ralston,et al.  Mineralisation defects with pamidronate therapy for Paget's disease , 1993, The Lancet.

[42]  A. Zwinderman,et al.  Improved treatment of paget's disease with dimethylaminohydroxypropylidene bisphosphonate , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  I. Fogelman,et al.  Bone scintigraphy following intravenous pamidronate for Paget's disease of bone. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  P. Geusens,et al.  Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study. , 1992, Arthritis and rheumatism.

[45]  I. Fogelman,et al.  Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD). , 1992, British journal of rheumatology.

[46]  R. Price,et al.  Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses , 1991, Clinical endocrinology.

[47]  D. Hosking,et al.  Treatment of paget's disease with intermittent low‐dose infusions of disodium pamidronate (APD) , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  J. Mckillop,et al.  Serial bone scans in Paget's disease: Development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment , 1990, Nuclear medicine communications.

[49]  J. Kanis,et al.  Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonate , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  Sandy Bidner,et al.  Femoral Fractures in Paget's Disease , 1989, Journal of orthopaedic trauma.

[51]  L. Mallette Successful treatment of resistant Paget's disease of bone with pamidronate. , 1989, Archives of internal medicine.

[52]  C. Löwik,et al.  Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  M. Audran,et al.  Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate , 1989, Clinical Rheumatology.

[54]  D. Anderson,et al.  Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate. , 1988, The British journal of radiology.

[55]  C. Gobelet,et al.  A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. , 1988, The American journal of medicine.

[56]  D. Anderson,et al.  Paget's disease of the orbit: before and after APD. , 1987, British medical journal.

[57]  S. Adami,et al.  The acute-phase response after bisphosphonate administration , 1987, Calcified Tissue International.

[58]  S. Papapoulos,et al.  Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). , 1987, British medical journal.

[59]  J. Kanis,et al.  Duration of effect of oral diphosphonate therapy in Paget's disease of bone. , 1987, The Quarterly journal of medicine.

[60]  D. Wattie,et al.  Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD. , 1987, The British journal of radiology.

[61]  C. Mautalen,et al.  Intravenous aminopropylidene bisphosphonate (APD) in the treatment of paget's bone disease , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[62]  P. Delmas,et al.  Skeletal distribution and biochemical parameters of Paget's disease. , 1987, Clinical orthopaedics and related research.

[63]  D. Thiebaud,et al.  Paget's disease of bone treated in five days with AHPrBP (APD) per Os , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  M. Zaaroor,et al.  Spinal cord compression in Paget's disease of bone with reference to sarcomatous degeneration and calcitonin treatment. , 1987, Surgical neurology.

[65]  S. Ralston,et al.  The effect of 1α‐hydroxyvitamin D3 on the mineralization defect in disodium etidronate‐treated paget's disease — a double‐blind randomized clinical study , 1987 .

[66]  D. Anderson,et al.  Lowdoseintravenous 3-amino-i- hydroxypropylide ne-1,1-bisphosph onate (APD)for thetreatment ofPaget's disease ofbone , 1986 .

[67]  S. Adami,et al.  Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate , 1986, Calcified Tissue International.

[68]  M. Peacock,et al.  Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. , 1986, British medical journal.

[69]  E. Pauwels,et al.  Quantitative bone scintigraphy in Paget's disease treated with APD. , 1985, The British journal of radiology.

[70]  R. Altman Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone. , 1985, The American journal of medicine.

[71]  J. Kanis,et al.  INTRAVENOUS CLODRONATE IN THE TREATMENT AND RETREATMENT OF PAGET'S DISEASE OF BONE , 1985, The Lancet.

[72]  J. Kanis,et al.  Carcinoma of the prostate: remission of paraparesis with inhibitors of bone resorption. , 1985, Postgraduate medical journal.

[73]  B. K. Prasad,et al.  Clinical experience with the use of two diphosphonates in the treatment of Paget's disease. , 1985, Annals of the rheumatic diseases.

[74]  S. Ralston,et al.  FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE , 1984, The Lancet.

[75]  M. Passeri,et al.  SIDE-EFFECTS OF SYNTHETIC SALMON AND HUMAN CALCITONIN , 1983, The Lancet.

[76]  G. Weisz Lumbar Spinal Canal Stenosis in Paget's Disease , 1983, Spine.

[77]  M. Chapuy,et al.  INTRAVENOUS ETIDRONATE FOR SPINAL CORD DYSFUNCTION DUE TO PAGET'S DISEASE , 1982, The Lancet.

[78]  J. Kanis,et al.  Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis? , 1981, The Journal of bone and joint surgery. British volume.

[79]  J. Kanis,et al.  Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone. , 1980, Arthritis and rheumatism.

[80]  L.,et al.  TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.) , 1979, The Lancet.

[81]  S. Wallach,et al.  Neurologic disturbances in Paget disease of bone , 1979, Neurology.

[82]  I. Chalmers,et al.  Long term effectiveness of low dose mithramycin for Paget's disease of bone. , 1979, Arthritis and rheumatism.

[83]  R. Altman,et al.  Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. , 1977, Annals of internal medicine.

[84]  M. Schumacher,et al.  Paget’s Disease with Spinal Cord Compression , 1977 .

[85]  M. Gardner,et al.  Paget's disease of bone in 14 British towns. , 1977, British medical journal.

[86]  S. Bowring,et al.  A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin. , 1977, The British journal of radiology.

[87]  J. A. Strong,et al.  Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses. , 1975, The Quarterly journal of medicine.

[88]  H. Wellman,et al.  Radiographs and scans in diagnosing symptomatic lesions of Paget's disease of bone (osteitis deformans). , 1974, Geriatrics.

[89]  R. Altman,et al.  Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate. , 1974, JAMA.

[90]  R. Russell,et al.  Diphosphonates in Paget's disease. , 1974, Lancet.

[91]  R. Altman,et al.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). , 1973, The New England journal of medicine.

[92]  W. Ryan Mithramycin in Paget's disease of bone. , 1973, Lancet.

[93]  R. Lindsay,et al.  Mithramycin in Paget's disease. , 1973, Lancet.

[94]  J. Evans,et al.  Mithramycin in the treatment of Paget's disease of bone. , 1972, The Journal of bone and joint surgery. American volume.

[95]  S. Wallach,et al.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone. , 1971, The Journal of clinical investigation.

[96]  Steinbach Hl Some roentgen features of Paget's disease. , 1961 .

[97]  F. Sim,et al.  Paget’s disease of the hip , 2004 .

[98]  S. Ortolani,et al.  Short-term intravenous therapy with Neridronate in Paget's disease. , 2002, Clinical and experimental rheumatology.

[99]  E. Siris,et al.  A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. , 1999, The American journal of medicine.

[100]  G. Gamble,et al.  Evidence for secular change in Paget's disease. , 1997, Bone.

[101]  C. Mautalen,et al.  Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile. , 1994, Drugs under experimental and clinical research.

[102]  S. Nade,et al.  Outcome after fractures of the femur in Paget's disease. , 1992, The Australian and New Zealand journal of surgery.

[103]  R. Mortimer,et al.  Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin. , 1991, Hormone research.

[104]  P. Burke,et al.  Improvement in the deformity of the face in Paget's disease treated with diphosphonates. , 1990, The Journal of bone and joint surgery. British volume.

[105]  J. Reginster,et al.  Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone. , 1988, Bone.

[106]  S. Ralston,et al.  The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study. , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[107]  C. Mautalen,et al.  Efficacy of the bisphosphonate APD in the control of Paget's bone disease. , 1985, Bone.

[108]  S. Adami,et al.  Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP). , 1984, Metabolic bone disease & related research.

[109]  E. Siris,et al.  Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy. , 1981, Metabolic bone disease & related research.

[110]  D. Heath The role of mithramycin in the management of Paget's disease. , 1981, Metabolic bone disease & related research.

[111]  R. Canfield,et al.  Diphosphonate therapy of paget's disease of bone. , 1977, The Journal of clinical endocrinology and metabolism.

[112]  M. Schumacher,et al.  Paget's disease with spinal cord compression. Favourable course after decompression and calcitonin treatment in two cases. , 1977, European neurology.

[113]  H. Wellman,et al.  Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease. , 1977, Clinical orthopaedics and related research.

[114]  P. Greenberg,et al.  Otological studies in patients with deafness due to Paget's disease before and after treatment with synthetic human calcitonin. , 1975, Acta oto-laryngologica.

[115]  R. Sherman,et al.  Roentgen diagnosis of Paget's disease (Osteitis deformans). The usual, the unusual, and the complications. , 1970, Dental radiography and photography.

[116]  H. Steinbach Some roentgen features of Paget's disease. , 1961, The American journal of roentgenology, radium therapy, and nuclear medicine.